Research Updates: multiple sclerosis

Below are short extracts from research updates about this subject - select more to read each item.

  1. Issue 295

    TAVAKOL abd COLLEAGUES, 1 Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran; 2 Drug Delivery Research Center (DDRC), Pharmaceutical Sciences Branch, Islamic Azad University, (IAUPS), Tehran, Iran; 3 Pharmaceut1


  2. Issue 290

    AMATYA and COLLEAGUES, 1 Department of Rehabilitation Medicine, Royal Melbourne Hospital, Royal Park Campus, Poplar Road, Parkville, Melbourne, Victoria, Australia, 3052 conducted a review with the aim to investigate the effectiveness and safety of 1


  3. Issue 288

    SAFAVI and COLLEAGUES 1 National Institutes of Neurological Disorders and Stroke, NIH, MD, USA; 2 Department of Neurology, Johns Hopkins University, MD, USA; 3 MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran1


  4. Issue 287

    FIORELLA and LORNA,  1 Universidad del Desarrollo-Clínica Alemana, Santiago, Chile; 2 Department of Neurology, Clínica Alemana, Santiago, Av Vitacura 5951, Vitacura, Santiago, Chile. lornag@gmail.1


  5. Issue 287

    MYCKO, 1 Department of Neurology, Faculty of Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland, Warszawska 30, 10-082 Olsztyn, Poland. opines that further research into the different role of B cells during1


  6. Issue 285

    RICCIO and ROSSANO, 1 Department of Sciences, University of Basilicata, Viale dell'Ateneo Lucano, 10, 85100, Potenza, Italy. 2 Department of Sciences, University of Basilicata, Viale1


  7. Issue 281

    LOONSTRA and COLLEAGUES, 1 Department of Neurology, Amsterdam Neuroscience, MS Center Amsterdam, Amsterdam University Medical Centers, VU University Medical Center, Amsterdam, The Netherlands; 2 Department of Neurology, Alrijne Hospital, Leiden, The1


  8. Issue 281

    DEMIR and COLLEAGUES, 1 Fırat University, Medical School, Neurology Department, Elazığ, Turkey; 2 Fırat University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Elazığ, Turkey conducted a study to investigate the 1


  9. Issue 279

    HESAMIAN and ESKANDARI, 1 Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; 2 Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran,


  10. Issue 267

    NAJAFI and COLLEAGUES, 1. Department of Exercise Physiology, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran; 2. Department of Exercise Physiology, Shiraz Branch, Islamic Azad University, Shiraz, Ir1


  11. Issue 260

    HA SANPOUR DEHKORDI, 1. Department of Medical-Surgical, Faculty of Nursing and Midwifery, Shahrekord University of Medical Sciences, Shahrekord, Iran - conducted a 1


  12. Issue 258

    GODALA and COLLEAGUES, 1. Medical University of Lodz, Poland: Department of Hygiene of Nutrition and Epidemiology; 2. Medical University of Lodz, Poland: Department of Internal Diseases and Nephrodiabetology; 3. Medical University of Lo1


  13. Issue 257

    NAZARI and COLLEAGUES, Isfahan Neurosciences Research Centre, Department of Adult Health Nursing, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran, School of Nursing and Midwifery, Isfahan University of Medical 1


  14. Issue 255

    FOX and COLLEAGUES, 1. E.E. Fox, PhD, Faculty of Health and Human Science, Plymouth University, Plymouth, United Kingdom; 2. A.D. Hough, PhD, Faculty of Health and Human Science, Plymouth University; 3. S. Cre1


  15. Issue 251

    RIO and RUIZ-PEÑA, 1. Centre d'Esclerosi Múltiple de Catalunya (CEM-Cat), Servei de Neurologia-Neuroimmunologia, Hospital Universitari Vall d'Hebron, Psg. Vall d'Hebron 119-120, Barcelona 08035, Spain.


  16. Issue 249

    WANG and COLLEAGUES, 1. Center of Acupuncture and Moxibustion, Beijing Chinese Medicine Hospital Affiliated to Capital Medical University, Beijing 100010, China; 2. Department of Neurology, Dongfang Hospital Affiliated to Beijing University of CM; 31


  17. Issue 236

    WIPFLER and COLLEAGUES, (1)Department of Neurology, Christian-Doppler-Klinik, Paracelsus Medical University  and Salzburger Landeskliniken, Ignaz-Harrer-Strasse 79, 5020, Salzburg, Austria evaluated circadian rhythmicity of inflammatory serum p1


  18. Issue 236

    ROSTI-OTAJÄRVI and HÄMÄLÄINEN, (1)Department of Neurology and Rehabilitation, Tampere University Hospital, Finland. evaluated the prevalence of behavi1


  19. Issue 235

    GUNN and COLLEAGUES, (1)School of Health Professions, Plymouth University, Plymouth, UK evaluated the risk factors associated with falling in people with MS.


  20. Issue 235

    ZHORNITSKY and COLLEAGUES,  (1)Multiple Sclerosis Program, Department of Clinical Neurosciences, University of Calgary, Canada conducted a systematic review to examine the known associations between prolactin (PRL) and MS to elucidate its po1


« Prev 1 2 3

ICAN 2024 Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

top of the page